Chi‐Fai Ng

24.1k total citations · 1 hit paper
409 papers, 7.3k citations indexed

About

Chi‐Fai Ng is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Chi‐Fai Ng has authored 409 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Pulmonary and Respiratory Medicine, 109 papers in Surgery and 80 papers in Urology. Recurrent topics in Chi‐Fai Ng's work include Prostate Cancer Diagnosis and Treatment (93 papers), Prostate Cancer Treatment and Research (89 papers) and Bladder and Urothelial Cancer Treatments (71 papers). Chi‐Fai Ng is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (93 papers), Prostate Cancer Treatment and Research (89 papers) and Bladder and Urothelial Cancer Treatments (71 papers). Chi‐Fai Ng collaborates with scholars based in Hong Kong, China and United Kingdom. Chi‐Fai Ng's co-authors include Jeremy Yuen‐Chun Teoh, Peter Ka‐Fung Chiu, Martin C. S. Wong, Franklin D. H. Fung, Colette Leung, William B. Goggins, Yü Huang, Xiaoqiang Yao, Chi‐Hang Yee and Eddie Chan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Chi‐Fai Ng

377 papers receiving 7.2k citations

Hit Papers

Global Incidence and Mortality for Prostate Cancer: Analy... 2016 2026 2019 2022 2016 100 200 300

Peers

Chi‐Fai Ng
John P. Richie United States
Peter H. Gann United States
William J. Aronson United States
Marc S. Penn United States
Chi‐Fai Ng
Citations per year, relative to Chi‐Fai Ng Chi‐Fai Ng (= 1×) peers Wen‐Jeng Wu

Countries citing papers authored by Chi‐Fai Ng

Since Specialization
Citations

This map shows the geographic impact of Chi‐Fai Ng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Fai Ng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Fai Ng more than expected).

Fields of papers citing papers by Chi‐Fai Ng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Fai Ng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Fai Ng. The network helps show where Chi‐Fai Ng may publish in the future.

Co-authorship network of co-authors of Chi‐Fai Ng

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Fai Ng. A scholar is included among the top collaborators of Chi‐Fai Ng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Fai Ng. Chi‐Fai Ng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nicoletti, Rossella, Andrea Alberti, Vineet Gauhar, et al.. (2025). Is there a role of PSMA-PET in focal therapy planning and follow-up?. Prostate Cancer and Prostatic Diseases. 29(1). 28–35. 1 indexed citations
2.
Siu, Brian, Alex Qinyang Liu, Chi‐Ho Leung, et al.. (2025). Treatment cycles per unit prostate volume (CPV) for transurethral water vapor therapy (Rezūm) in catheter-dependent patients. Prostate Cancer and Prostatic Diseases. 29(1). 132–137. 1 indexed citations
3.
Zhang, Kai, Jeremy Yuen‐Chun Teoh, M. Pilar Laguna Pes, et al.. (2025). The diagnostic value of MRI for persistent prostate cancer following irreversible electroporation focal therapy. British Journal of Urology. 136(1). 120–127.
4.
Leung, Chi‐Ho, et al.. (2025). Presentation, management, and clinical outcomes of von Hippel–Lindau syndrome. Hong Kong Medical Journal. 31(5). 355–362.
6.
Ng, Chi‐Fai, Stephen L. Chan, Ka Man Cheung, et al.. (2024). 1238TiP Combining immunotherapy with Trop2 ADc in early stage non-small cell lung cancer (CITADEL). Annals of Oncology. 35. S792–S793.
7.
Zhang, Kai, et al.. (2024). Irreversible Electroporation for the Focal Treatment of Prostate Cancer: A Systematic Review. The World Journal of Men s Health. 43(2). 321–321. 6 indexed citations
8.
Lee, Yan Hiu Athena, Jeffrey Shi Kai Chan, Chi‐Ho Leung, et al.. (2024). Comparison of infection risk between enzalutamide and abiraterone in patients with prostate cancer. Cancer. 130(22). 3826–3835. 1 indexed citations
9.
Wong, Christine Yim‐Ping, Xiaofan Ding, Chit Chow, et al.. (2024). The establishment of kidney cancer organoid line in drug testing. Cancer Medicine. 13(12). e7432–e7432. 2 indexed citations
10.
Peng, Qiang, Yu Chen, Tingting Xie, et al.. (2024). PiRNA-4447944 promotes castration-resistant growth and metastasis of prostate cancer by inhibiting NEFH expression through forming the piRNA-4447944-PIWIL2-NEFH complex. International Journal of Biological Sciences. 20(9). 3638–3655. 6 indexed citations
12.
Lee, Yan Hiu Athena, Jeffrey Shi Kai Chan, Jeremy Man Ho Hui, et al.. (2023). Statin use and mortality risk in Asian patients with prostate cancer receiving androgen deprivation therapy: A population‐based cohort study. Cancer Medicine. 13(1). e6826–e6826. 3 indexed citations
13.
Lee, Yan Hiu Athena, Jeremy Man Ho Hui, Cheuk To Chung, et al.. (2023). Metformin use and hospital attendance‐related resources utilization among diabetic patients with prostate cancer on androgen deprivation therapy: A population‐based cohort study. Cancer Medicine. 12(8). 9128–9132. 6 indexed citations
14.
Wong, Martin C. S., Junjie Huang, Haoxiang Wang, et al.. (2023). Risk prediction of bladder cancer among person with diabetes: A derivation and validation study. Diabetic Medicine. 41(3). e15199–e15199. 1 indexed citations
15.
Chiu, Peter Ka‐Fung, Yuen Ting Lam, Sunny Y. Wong, et al.. (2020). Prostate cancer screening program with PSA, Prostate Health Index and MRI in a prospective cohort of Hong Kong Chinese men – an interim result. European Urology Open Science. 19. e162–e162.
16.
Chiu, Peter Ka‐Fung, et al.. (2020). Transperineal microwave ablation of prostate cancer guided by MRI ultrasound fusion and organ based tracking technology. European Urology Open Science. 19. e2344–e2344. 1 indexed citations
17.
Teoh, Jeremy Yuen‐Chun, et al.. (2020). A newly developed computer-aided endoscopic diagnostic system for bladder cancer detection. European Urology Open Science. 19. e1364–e1365. 4 indexed citations
18.
Yee, Chi‐Hang, et al.. (2020). Technique of total robotic augmentation gastrocystoplasty. SHILAP Revista de lepidopterología. 5. 100024–100024.
19.
Leung, David, Peter Ka‐Fung Chiu, Chi‐Fai Ng, & Jeremy Yuen‐Chun Teoh. (2020). Role of pre-biopsy multiparametric MRI in prostate cancer diagnosis: Evidence from the literature. SHILAP Revista de lepidopterología. 47(1). S65–S70. 4 indexed citations
20.
Wang, Yuliang, Kexin Xu, Hao Hu, et al.. (2018). Nuclear Receptor LRH-1 Functions to Promote Castration-Resistant Growth of Prostate Cancer via Its Promotion of Intratumoral Androgen Biosynthesis. Cancer Research. 78(9). 2205–2218. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026